GlassScriptPhysician profile
Wade S Smith
NPI 1386678456
$658.42
in general payments reported to CMS, 2019-2025
8 companies · $147 in 2025
The $147 reported for 2025 was less than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $27.53 · 2022: $79.53 · 2023: $321 · 2024: $83.69 · 2025: $147.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $551.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $551.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $380.09 | 2022-2025 | Euflexxa |
| Depuy Synthes Sales INC. | $93.08 | 2022-2025 | Monovisc |
| Vertex Pharmaceuticals Incorporated | $46.25 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $38.38 | 2022-2023 | Iovera |
| Bioventus LLC | $37.97 | 2023-2025 | Durolane, Durolane |
| Smith+Nephew, INC. | $27.53 | 2021 | |
| Molnlycke Health Care US, LLC | $20.13 | 2023 | Mepilex Border Ag, Mepilex Border Post-Op, Mepilex Border Flex |
| Fidia Pharma USA INC. | $14.99 | 2025 | Triluron, Hymovis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wade Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.